Ocean Biomedical, Inc.
OCEA· OTC
OCEAOcean Biomedical, Inc.
Filed Oct 17, 2022 · 10-Q · 17 days after period end · 0001493152-22-028552
| Metric | Q3 2022 | Q3 2021 |
|---|---|---|
| Net Income | -$1.02M | -$42.55K |
| EPS Diluted | -$0.16 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ocean Biomedical, Inc. · CIK 1869974 · Engraved from SEC EDGAR
ended Sep 30, 2022 · filed Oct 17, 2022 · 17 d after period end
